NHS Framework Agreement for the supply of Direct Oral Anticoagulants (DOACs) for the NHS in England
Awarded by NHS England · to Bristol Myers Squibb · 2021-11-15T00:00:00Z · £3,185,000,000
Description
NHS Framework Agreement for the supply of Direct Oral Anticoagulants (DOACs) for the NHS in England. Also known as Novel Oral Anticoagulants (NOACs). Period of Framework: 01/01/2022 - 31/03/2024 with an option to extend (at the Authority's discretion) for a further period (or periods) up to a total of 12 months (i.e. total possible framework duration of 39 months)
- Supplier
- Bristol Myers Squibb
- Buyer
- NHS England
- Value
- £3,185,000,000
- Category (CPV)
- Pharmaceutical products
- Award date
- 2021-11-15T00:00:00Z
Full CPV hierarchy, related awards from the same supplier and buyer, and any declared MP interest overlaps load below when JavaScript is enabled.